This selective small-molecule inhibitor exerts the strongest effect on the least-studied isoform, JNK3, which is hypothesised as a target in NB due to its expression in neuronal tissue and potential molecular involvement in apoptosis and oxidative stress response [19,31]. This evidence concerns the gene MAPK10 and neuroblastoma.